RxReport.ai is a next-generation platform designed to advance real-time drug safety intelligence, support pharmacovigilance, and amplify trust in medication data — powered by AI and built to serve pharmacists, providers, and public health leaders.
Annual emergency visits in the U.S. due to Adverse Drug Events, with nearly 500,000 requiring hospitalization (CDC, 2023)
Patients hospitalized yearly from medication complications (AHRQ Patient Safety Network, 2024)
Annual fatalities from medication errors and adverse events (JAMA analysis, 2023)
Annual healthcare costs associated with adverse drug events (NIH & Health Economics Research, 2024)
Sources: Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Journal of the American Medical Association (JAMA), and National Institutes of Health (NIH). All 2025 projections based on current trend analysis from the Institute for Safe Medication Practices.
Track medication events across populations in real-time, identifying patterns before they become widespread problems.
Leverage AI-powered insights to anticipate potential safety concerns based on real-world outcomes and patient data.
Generate comprehensive safety documentation for clinical education, regulatory submissions, and public health initiatives.
Seamlessly incorporate safety data into existing pharmacy systems, EHRs, and clinical decision support tools.
Enhance medication safety protocols and reduce adverse events through proactive monitoring and intervention.
Access anonymized real-world data to advance pharmacovigilance research and improve clinical outcomes.
Empower members with cutting-edge tools to improve patient safety and enhance professional practice.
Integrate robust medication safety data into decision support systems and digital health platforms.
Turning complex data into clinical insights
Trained to detect safety signals and demographic impacts
FDA MedWatch, anonymized ADEs, pharmacovigilance datasets
Converting patient-reported events into structured data
Our platform applies advanced AI techniques to transform disparate medication safety data into a comprehensive intelligence system that grows smarter with each new data point.
Provide healthcare stakeholders with early access to emerging medication safety signals.
Facilitate evidence-based discussions between providers and patients about medication risks.
Support targeted initiatives that prevent adverse events through improved awareness.
Build confidence in medication safety through data-driven transparency and information sharing.
Join our early adopter program to help shape the future of medication safety intelligence, with customized implementation support and priority feature development.
Integrate RxReport.ai capabilities into your existing platforms through flexible licensing options tailored to your organization's specific needs and user base.
Partner with our data science team to advance pharmacovigilance research, develop novel safety algorithms, or create specialized applications for specific medication classes.
Leverage our platform for continuing education initiatives, pharmacy school training, or public health campaigns focused on medication safety awareness.
RxReport.ai can be fully customized with your organization's branding, user experience, and workflow requirements while maintaining all core functionality and data intelligence capabilities.
Acquisition includes complete intellectual property rights to our proprietary algorithms, data processing systems, and user interfaces, providing a significant competitive advantage in the medication safety space.
Our technical team can provide comprehensive knowledge transfer, implementation support, and ongoing consultation to ensure seamless integration with your existing technology infrastructure.
The platform offers multiple expansion pathways including integration with telehealth services, pharmaceutical research applications, and international market adaptation with region-specific regulatory features.
RxReport.ai